abSorbable vErsus Non-absorbable SuturEs for Wound Closure in Carpal Tunnel Release

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorGelre Hospitals

About this trial

Carpal Tunnel Syndrome is a prevalent condition, up to 9% in women and 0.6% in men. Surgical decompression in the most effective treatment. After surgery, approximately 1,8% of the patients develop a wound infection. Possibly, the type of sutures used can influence the prevalence of wound infection. In this RCT the incidence of infection is investigated between the use of absorbable versus non-absorbable sutures in carpal tunnel release.

Eligibility criteria

Qualifiers

None

Disqualifiers

carpal tunnel syndrome which has yet been operated

injection with corticosteroids

Trial design

Treatments tested in this trial

  • Carpal Tunnel Release

Treatment groups

2,604 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Gelre Hospitals

Lead sponsor

Deventer Ziekenhuis

Collaborator